Is Invivyd Stock a Good Investment?
Invivyd Investment Advice | IVVD |
- Examine Invivyd's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Invivyd's leadership team and their track record. Good management can help Invivyd navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Invivyd's business and its evolving consumer preferences.
- Compare Invivyd's performance and market position to its competitors. Analyze how Invivyd is positioned in terms of product offerings, innovation, and market share.
- Check if Invivyd pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Invivyd's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Invivyd stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Invivyd is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Invivyd Stock
Researching Invivyd's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 18.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.01. Some equities with similar Price to Book (P/B) outperform the market in the long run. Invivyd recorded a loss per share of 1.95. The entity had not issued any dividends in recent years.
To determine if Invivyd is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Invivyd's research are outlined below:
| Invivyd generated a negative expected return over the last 90 days | |
| Invivyd has high historical volatility and very poor performance | |
| Invivyd has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (198.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Invivyd currently holds about 418.67 M in cash with (173.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Invivyd has a frail financial position based on the latest SEC disclosures | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Invivyd Price Target Cut to 3.55 by Analysts at Morgan Stanley |
Invivyd uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Invivyd. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Invivyd's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Invivyd's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Invivyd's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-10 | 2022-09-30 | -0.49 | -0.42 | 0.07 | 14 | ||
2024-05-09 | 2024-03-31 | -0.47 | -0.38 | 0.09 | 19 | ||
2022-08-15 | 2022-06-30 | -0.57 | -0.47 | 0.1 | 17 | ||
2022-05-13 | 2022-03-31 | -0.82 | -0.93 | -0.11 | 13 | ||
2023-08-10 | 2023-06-30 | -0.34 | -0.46 | -0.12 | 35 | ||
2023-11-09 | 2023-09-30 | -0.5 | -0.36 | 0.14 | 28 | ||
2023-03-23 | 2022-12-31 | -0.39 | -0.25 | 0.14 | 35 | ||
2024-11-07 | 2024-09-30 | -0.35 | -0.51 | -0.16 | 45 |
Know Invivyd's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Invivyd is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Invivyd backward and forwards among themselves. Invivyd's institutional investor refers to the entity that pools money to purchase Invivyd's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-06-30 | 1.6 M | Millennium Management Llc | 2024-06-30 | 1.1 M | State Street Corp | 2024-06-30 | 982.7 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 786.9 K | Jacobs Levy Equity Management, Inc. | 2024-06-30 | 687.9 K | Deutsche Bank Ag | 2024-06-30 | 646.9 K | Duquesne Family Office Llc | 2024-06-30 | 571.4 K | Northern Trust Corp | 2024-09-30 | 568.4 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 488.2 K | Maverick Capital Ltd | 2024-06-30 | 11.8 M | Deep Track Capital, Lp | 2024-09-30 | 11 M |
Invivyd's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 83.9 M.Market Cap |
|
Invivyd's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.87) | (0.91) | |
| Return On Capital Employed | (1.16) | (1.22) | |
| Return On Assets | (0.87) | (0.91) | |
| Return On Equity | (1.12) | (1.06) |
Determining Invivyd's profitability involves analyzing its financial statements and using various financial metrics to determine if Invivyd is a good buy. For example, gross profit margin measures Invivyd's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Invivyd's profitability and make more informed investment decisions.
Please note, the presentation of Invivyd's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Invivyd's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Invivyd's management manipulating its earnings.
Evaluate Invivyd's management efficiency
Invivyd has return on total asset (ROA) of (0.5356) % which means that it has lost $0.5356 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9656) %, meaning that it created substantial loss on money invested by shareholders. Invivyd's management efficiency ratios could be used to measure how well Invivyd manages its routine affairs as well as how well it operates its assets and liabilities. As of November 23, 2024, Return On Tangible Assets is expected to decline to -0.91. In addition to that, Return On Capital Employed is expected to decline to -1.22. At present, Invivyd's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.01, whereas Non Current Assets Total are forecasted to decline to about 3.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.62 | 1.87 | |
| Tangible Book Value Per Share | 1.62 | 1.87 | |
| Enterprise Value Over EBITDA | (1.19) | (1.24) | |
| Price Book Value Ratio | 2.43 | 2.55 | |
| Enterprise Value Multiple | (1.19) | (1.24) | |
| Price Fair Value | 2.43 | 2.55 | |
| Enterprise Value | 233.1 M | 221.4 M |
The leadership approach at Invivyd's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 0.656 |
Basic technical analysis of Invivyd Stock
As of the 23rd of November, Invivyd retains the Risk Adjusted Performance of 0.0068, market risk adjusted performance of 0.0013, and Standard Deviation of 8.04. Invivyd technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Invivyd risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Invivyd is priced fairly, providing market reflects its last-minute price of 0.7 per share. As Invivyd is a penny stock we also advise to confirm its jensen alpha numbers.Invivyd's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Invivyd insiders, such as employees or executives, is commonly permitted as long as it does not rely on Invivyd's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Invivyd insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Green Julie over three months ago Acquisition by Green Julie of 240000 shares of Invivyd at 4.43 subject to Rule 16b-3 | ||
Lee Timothy Edward over three months ago Insider Trading | ||
Mcguire Terrance over six months ago Acquisition by Mcguire Terrance of 50000 shares of Invivyd at 2.21 subject to Rule 16b-3 | ||
Gupta Srishti over six months ago Insider Trading | ||
Lindenboom Christine over six months ago Acquisition by Lindenboom Christine of 150000 shares of Invivyd subject to Rule 16b-3 | ||
Price Stacy over six months ago Acquisition by Price Stacy of 400000 shares of Invivyd subject to Rule 16b-3 | ||
Mcguire Terrance over a year ago Acquisition by Mcguire Terrance of 50000 shares of Invivyd subject to Rule 16b-3 |
Understand Invivyd's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Invivyd's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0068 | |||
| Market Risk Adjusted Performance | 0.0013 | |||
| Mean Deviation | 5.37 | |||
| Coefficient Of Variation | (34,148) | |||
| Standard Deviation | 8.04 | |||
| Variance | 64.61 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.01) | |||
| Maximum Drawdown | 56.4 | |||
| Value At Risk | (11.30) | |||
| Potential Upside | 13.33 | |||
| Skewness | 0.0899 | |||
| Kurtosis | 3.29 |
| Risk Adjusted Performance | 0.0068 | |||
| Market Risk Adjusted Performance | 0.0013 | |||
| Mean Deviation | 5.37 | |||
| Coefficient Of Variation | (34,148) | |||
| Standard Deviation | 8.04 | |||
| Variance | 64.61 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.01) | |||
| Maximum Drawdown | 56.4 | |||
| Value At Risk | (11.30) | |||
| Potential Upside | 13.33 | |||
| Skewness | 0.0899 | |||
| Kurtosis | 3.29 |
Consider Invivyd's intraday indicators
Invivyd intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Invivyd stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Invivyd time-series forecasting models is one of many Invivyd's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Invivyd's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Invivyd Stock media impact
Far too much social signal, news, headlines, and media speculation about Invivyd that are available to investors today. That information is available publicly through Invivyd media outlets and privately through word of mouth or via Invivyd internal channels. However, regardless of the origin, that massive amount of Invivyd data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Invivyd news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Invivyd relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Invivyd's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Invivyd alpha.
Invivyd Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Invivyd can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Invivyd Corporate Management
| Laura Walker | CoFounder Officer | Profile | |
| Elham PharmD | Chief Officer | Profile | |
| Peter MD | Chief Officer | Profile | |
| Robert Allen | Chief Officer | Profile | |
| Jill JD | Chief Secretary | Profile | |
| Mark Wingertzahn | Senior Affairs | Profile | |
| Timothy Lee | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invivyd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Invivyd Stock refer to our How to Trade Invivyd Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Invivyd. If investors know Invivyd will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Invivyd listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.95) | Revenue Per Share 0.02 | Return On Assets (0.54) | Return On Equity (0.97) |
The market value of Invivyd is measured differently than its book value, which is the value of Invivyd that is recorded on the company's balance sheet. Investors also form their own opinion of Invivyd's value that differs from its market value or its book value, called intrinsic value, which is Invivyd's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invivyd's market value can be influenced by many factors that don't directly affect Invivyd's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Invivyd's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Invivyd is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invivyd's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.